LANTHANUM CARBONATE | A090977 | BARR LABORATORIES INC A WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Shire Development Inc. (Shire) - Citizen Petition FDA-2010-P-0309 Shire Development Inc. filed this citizen petition under sections 505(j) and 505(q) requesting that the FDA require all abbreviated new drug applications and 505(b)(2) new drug applications for generic or follow-on formulations of Fosrenol (lanthanum carbonate) oral chewable tablets to include chara | 505(q) | 2010-07-08 | Partially Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.